Ubs Asset Management Americas Inc Mirati Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $9.77 Million - $14.5 Million	-232,660 Reduced 78.02%	65,534 $3.85 Million
Q3 2023 Nov 13, 2023	SELL	$27.8 - $45.35 $128,630 - $209,834	-4,627 Reduced 1.53%	298,194 $13 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $2.3 Million - $3.41 Million	62,919 Added 26.23%	302,821 $11.3 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $1.57 Million - $3.75 Million	37,976 Added 18.81%	239,902 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $921,833 - $1.34 Million	-15,493 Reduced 7.13%	201,926 $14.1 Million
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $2.75 Million - $6.23 Million	-70,241 Reduced 24.42%	217,419 $14.6 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $18.8 Million - $37.4 Million	-247,405 Reduced 46.24%	287,660 $23.7 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $16.9 Million - $24.4 Million	128,065 Added 31.47%	535,065 $78.5 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $3.14 Million - $4.21 Million	-23,751 Reduced 5.51%	407,000 $72 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $4.8 Million - $5.99 Million	-33,339 Reduced 7.18%	430,751 $69.6 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $4.44 Million - $6.19 Million	-27,926 Reduced 5.68%	464,090 $79.5 Million
Q4 2020 Mar 01, 2021	SELL	$162.05 - $240.27 $25 Million - $37.1 Million	-154,280 Reduced 23.87%	492,016 $108 Million
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $4.72 Million - $6.97 Million	41,646 Added 6.89%	646,296 $107 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $445,525 - $744,852	6,187 Added 1.03%	604,650 $69 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $16.3 Million - $27.2 Million	233,931 Added 64.17%	598,463 $46 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $9.12 Million - $16.6 Million	128,939 Added 54.73%	364,532 $47 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $16.7 Million - $23.4 Million	213,716 Added 976.9%	235,593 $18.4 Million
Q2 2019 Aug 15, 2019	BUY	$59.49 - $104.71 $661,350 - $1.16 Million	11,117 Added 103.32%	21,877 $0
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $169,362 - $306,326	3,880 Added 56.4%	10,760 $0
Q4 2018 Feb 13, 2019	SELL	$32.0 - $47.43 $71,040 - $105,294	-2,220 Reduced 24.4%	6,880 $291,000
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $14,130 - $18,810	300 Added 3.41%	9,100 $0
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $229,240 - $461,120	8,800 New	8,800 $0

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account